APOE基因型与脂肪酸水平对卒中、冠心病及死亡风险的影响
本研究纳入FHS研究943人与3C波尔多研究1406人,用气相色谱法测定基线血浆二十二碳六烯酸、亚油酸、花生四烯酸和棕榈酸水平,按APOE-ε4基因型分层用Cox模型分析脂肪酸与卒中、冠心病及全因死亡的关联,并做随机效应Meta分析。结果显示仅APOE-ε4携带者中亚油酸升高与卒中及死亡风险降低相关,棕榈酸升高与卒中及冠心病风险增加相关。
要点
- 仅APOE-ε4携带者中亚油酸每升高1个SD与全因卒中风险降低相关(HR 0.54)。
- APOE-ε4携带者中棕榈酸每升高1个SD与缺血性卒中风险升高相关(HR 1.76)。
- 二十二碳六烯酸和花生四烯酸的结果在队列间存在异质性。
核心结论
- 在APOE-ε4携带者中,亚油酸升高与卒中和死亡风险降低相关,棕榈酸升高与卒中和冠心病风险增加相关。
- 作者认为APOE-ε4携带者可能对脂肪酸的心血管与死亡影响更敏感,机制尚待进一步研究。
研究设计与样本
- 研究纳入FHS研究943人与3C波尔多研究1406人,平均年龄74岁,女性占61%,APOE-ε4携带者483人(21%)。
- 基线用气相色谱法测定血浆二十二碳六烯酸、亚油酸、花生四烯酸和棕榈酸。
- 两队列分别用Cox模型按APOE基因型分层分析≤10年随访事件,并用随机效应模型Meta分析汇总统计量。
主要发现
- 仅APOE-ε4携带者中,亚油酸每升高1个SD与全因卒中风险降低相关(HR 0.54,95%CI 0.38-0.78)。
- 仅APOE-ε4携带者中,亚油酸每升高1个SD与缺血性卒中(HR 0.48,95%CI 0.33-0.71)和全因死亡(HR 0.70,95%CI 0.57-0.85)风险降低相关。
- 仅APOE-ε4携带者中,棕榈酸每升高1个SD与全因卒中(HR 1.58,95%CI 1.16-2.17)、缺血性卒中(HR 1.76,95%CI 1.26-2.45)和冠心病(HR 1.48,95%CI 1.09-2.01)风险增加相关。
- 二十二碳六烯酸和花生四烯酸的结果在队列间存在异质性。
临床怎么用
- 对APOE-ε4携带者,可关注血浆亚油酸与棕榈酸水平作为卒中及冠心病风险的潜在参考指标。
- 上述关联为探索性结果,尚不能据此制定膳食脂肪酸干预建议。
局限性
- 作者将结果定性为探索性,机制尚未阐明。
- 二十二碳六烯酸和花生四烯酸结果在队列间存在异质性。
- 随访时间≤10年,仅基于两个队列的血浆脂肪酸单次基线测量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- The role of dietary fat on cardiovascular health and mortality remains under debate. Because the APOE is central to the transport and metabolism of lipids, we examined associations between plasma fatty acids and the risk of stroke, coronary heart disease, and mortality by APOE-ε4 genotype. Methods- We included 943 FHS (Framingham Heart Study) and 1406 3C (Three-City) Bordeaux Study participants. Plasma docosahexaenoic, linoleic, arachidonic, and palmitic fatty acids were measured at baseline by gas chromatography. All-cause stroke, ischemic stroke, coronary heart disease, and all-cause mortality events were identified prospectively using standardized protocols. Each cohort used Cox models to separately relate fatty acid levels to the risk of developing each event during ≤10 years of follow-up adjusting for potential confounders and stratifying by APOE genotype (ε4 carriers versus noncarriers). We then meta-analyzed summary statistics using random-effects models. Results- On average, participants had a mean age of 74 years, 61% were women, and 21% (n=483) were APOE-ε4 carriers. Meta-analysis results showed that, only among APOE-ε4 carriers, every SD unit increase in linoleic acid was associated with a reduced risk of all-cause stroke (hazard ratio [HR], 0.54 [95% CI, 0.38-0.78]), ischemic stroke (HR, 0.48 [95% CI, 0.33-0.71]), and all-cause mortality (HR, 0.70 [95% CI, 0.57-0.85]). In contrast, every SD unit increase in palmitic acid was related to an increased risk of all-cause stroke (HR, 1.58 [95% CI, 1.16-2.17]), ischemic stroke (HR, 1.76 [95% CI, 1.26-2.45]), and coronary heart disease (HR, 1.48 [95% CI, 1.09-2.01]), also in APOE-ε4 carriers only. Results for docosahexaenoic acid and arachidonic acid were heterogeneous between cohorts. Conclusions- These exploratory results suggest that APOE-ε4 carriers may be more susceptible to the beneficial or adverse impact of fatty acids on cardiovascular disease and mortality. In this subgroup, higher linoleic acid was protective for stroke and mortality, whereas palmitic acid was a risk factor for stroke and coronary heart disease. The mechanisms underlying these novel findings warrant further investigation.
引用
- Satizabal CL, Samieri C, Davis-Plourde KL, et al. APOE and the Association of Fatty Acids With the Risk of Stroke, Coronary Heart Disease, and Mortality. Stroke. 2018. PMID: 30571417. doi:10.1161/STROKEAHA.118.022132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。